Exclusive Partnership with Supplier in the Middle East
Filed with ASX · · 2 pages · English
Earlier from ReNerve
Later from ReNerve
- ReNerve - Q2 FY25 Activities Report & Appendix 4C
- 1HFY25 Appendix 4D and Half Year Report
- 1HFY25 Results Announcement
- Clinical Outcome Demonstrates Material Benefits for Patients
- Response to ASX Aware Letter
Follow ReNerve into a list and get an email when it puts out news.
Follow ReNerve